<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 29 Jul 2026 16:06:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Mar+31/26834944.html</link>
   <description>si-local-file:///var/storage/secattach/20260729/26834944.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Mar+31/26834944.html</guid>
   <pubDate>Wed, 29 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Mar+31/26834944.html</link>
   <description>si-local-file:///var/storage/secattach/20260729/26834944.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Mar+31/26834944.html</guid>
   <pubDate>Wed, 29 Jul 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones</title>
   <link>http://www.streetinsider.com/Press+Releases/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</link>
   <description>&lt;p&gt;DENVER, June  29, 2026  (GLOBE NEWSWIRE) -- (&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=aQOc0YN9hLEiY8gzocaZsNgBhcfDeK0VJP4DhglSHMOa-HXjF1J517DRMv-Iv5V2Uq9WxLauTwfWf0vZuSgycr9YgjqDnvGGJyQ-R0RSfQg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;247marketnews.com&lt;/u&gt;&lt;/a&gt;) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization.&lt;/p&gt;  &lt;p&gt;&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Uax7tMXKpgs_84TWdlsgIlK8QTXVktAuzDz5Ufnc33zottBl7Y8uhowrmgqvRJ4u09dv_T52EMJniol0fq4yDBgQerCLSsGBlJaOZV96q2TQ0FJb1oIE25aRqm9oMcRO&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Universe Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; &lt;strong&gt;(NASDAQ: UPC)&lt;/strong&gt; announced a definitive agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The all-stock acquisition, valued at approximately $10.75 million, is expected</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</guid>
   <pubDate>Mon, 29 Jun 2026 09:50:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DCOY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones</title>
   <link>http://www.streetinsider.com/Press+Releases/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</link>
   <description>&lt;p&gt;DENVER, June  29, 2026  (GLOBE NEWSWIRE) -- (&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=aQOc0YN9hLEiY8gzocaZsNgBhcfDeK0VJP4DhglSHMOa-HXjF1J517DRMv-Iv5V2Uq9WxLauTwfWf0vZuSgycr9YgjqDnvGGJyQ-R0RSfQg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;247marketnews.com&lt;/u&gt;&lt;/a&gt;) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization.&lt;/p&gt;  &lt;p&gt;&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Uax7tMXKpgs_84TWdlsgIlK8QTXVktAuzDz5Ufnc33zottBl7Y8uhowrmgqvRJ4u09dv_T52EMJniol0fq4yDBgQerCLSsGBlJaOZV96q2TQ0FJb1oIE25aRqm9oMcRO&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Universe Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; &lt;strong&gt;(NASDAQ: UPC)&lt;/strong&gt; announced a definitive agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The all-stock acquisition, valued at approximately $10.75 million, is expected</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</guid>
   <pubDate>Mon, 29 Jun 2026 09:50:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DCOY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones</title>
   <link>http://www.streetinsider.com/Press+Releases/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</link>
   <description>&lt;p&gt;DENVER, June  29, 2026  (GLOBE NEWSWIRE) -- (&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=aQOc0YN9hLEiY8gzocaZsNgBhcfDeK0VJP4DhglSHMOa-HXjF1J517DRMv-Iv5V2Uq9WxLauTwfWf0vZuSgycr9YgjqDnvGGJyQ-R0RSfQg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;247marketnews.com&lt;/u&gt;&lt;/a&gt;) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization.&lt;/p&gt;  &lt;p&gt;&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Uax7tMXKpgs_84TWdlsgIlK8QTXVktAuzDz5Ufnc33zottBl7Y8uhowrmgqvRJ4u09dv_T52EMJniol0fq4yDBgQerCLSsGBlJaOZV96q2TQ0FJb1oIE25aRqm9oMcRO&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Universe Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; &lt;strong&gt;(NASDAQ: UPC)&lt;/strong&gt; announced a definitive agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The all-stock acquisition, valued at approximately $10.75 million, is expected</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</guid>
   <pubDate>Mon, 29 Jun 2026 09:50:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DCOY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones</title>
   <link>http://www.streetinsider.com/Globe+Newswire/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</link>
   <description>&lt;p&gt;DENVER, June  29, 2026  (GLOBE NEWSWIRE) -- (&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=aQOc0YN9hLEiY8gzocaZsNgBhcfDeK0VJP4DhglSHMOa-HXjF1J517DRMv-Iv5V2Uq9WxLauTwfWf0vZuSgycr9YgjqDnvGGJyQ-R0RSfQg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;247marketnews.com&lt;/u&gt;&lt;/a&gt;) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization.&lt;/p&gt;  &lt;p&gt;&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Uax7tMXKpgs_84TWdlsgIlK8QTXVktAuzDz5Ufnc33zottBl7Y8uhowrmgqvRJ4u09dv_T52EMJniol0fq4yDBgQerCLSsGBlJaOZV96q2TQ0FJb1oIE25aRqm9oMcRO&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Universe Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; &lt;strong&gt;(NASDAQ: UPC)&lt;/strong&gt; announced a definitive agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The all-stock acquisition, valued at approximately $10.75 million, is expected</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</guid>
   <pubDate>Mon, 29 Jun 2026 09:50:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DCOY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones</title>
   <link>http://www.streetinsider.com/Globe+Newswire/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</link>
   <description>&lt;p&gt;DENVER, June  29, 2026  (GLOBE NEWSWIRE) -- (&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=aQOc0YN9hLEiY8gzocaZsNgBhcfDeK0VJP4DhglSHMOa-HXjF1J517DRMv-Iv5V2Uq9WxLauTwfWf0vZuSgycr9YgjqDnvGGJyQ-R0RSfQg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;247marketnews.com&lt;/u&gt;&lt;/a&gt;) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization.&lt;/p&gt;  &lt;p&gt;&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Uax7tMXKpgs_84TWdlsgIlK8QTXVktAuzDz5Ufnc33zottBl7Y8uhowrmgqvRJ4u09dv_T52EMJniol0fq4yDBgQerCLSsGBlJaOZV96q2TQ0FJb1oIE25aRqm9oMcRO&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Universe Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; &lt;strong&gt;(NASDAQ: UPC)&lt;/strong&gt; announced a definitive agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The all-stock acquisition, valued at approximately $10.75 million, is expected</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</guid>
   <pubDate>Mon, 29 Jun 2026 09:50:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DCOY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones</title>
   <link>http://www.streetinsider.com/Globe+Newswire/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</link>
   <description>&lt;p&gt;DENVER, June  29, 2026  (GLOBE NEWSWIRE) -- (&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=aQOc0YN9hLEiY8gzocaZsNgBhcfDeK0VJP4DhglSHMOa-HXjF1J517DRMv-Iv5V2Uq9WxLauTwfWf0vZuSgycr9YgjqDnvGGJyQ-R0RSfQg=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;247marketnews.com&lt;/u&gt;&lt;/a&gt;) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization.&lt;/p&gt;  &lt;p&gt;&lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Uax7tMXKpgs_84TWdlsgIlK8QTXVktAuzDz5Ufnc33zottBl7Y8uhowrmgqvRJ4u09dv_T52EMJniol0fq4yDBgQerCLSsGBlJaOZV96q2TQ0FJb1oIE25aRqm9oMcRO&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;&lt;strong&gt;Universe Pharmaceuticals&lt;/strong&gt;&lt;/a&gt; &lt;strong&gt;(NASDAQ: UPC)&lt;/strong&gt; announced a definitive agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The all-stock acquisition, valued at approximately $10.75 million, is expected</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/4+Sizzling+Biotech+and+Healthcare+Companies+Reporting+Strategic+Milestones/26703277.html</guid>
   <pubDate>Mon, 29 Jun 2026 09:50:32 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DCOY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRDN</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Jun+26/26698728.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698728.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Jun+26/26698728.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: Jun 26</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Jun+26/26698728.html</link>
   <description>si-local-file:///var/storage/secattach/20260626/26698728.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Jun+26/26698728.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Universe Pharmaceuticals to acquire five-patent portfolio for $10.75M</title>
   <link>http://www.streetinsider.com/Corporate+News/Universe+Pharmaceuticals+to+acquire+five-patent+portfolio+for+%2410.75M/26698691.html</link>
   <description>&lt;p&gt;Universe Pharmaceuticals INC (NASDAQ: UPC), a pharmaceutical producer and distributor based in Ji'an, Jiangxi, China, has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited, a company holding five patents in China, for $10,751,000.&lt;/p&gt;&lt;p&gt;The purchase price will be paid entirely in stock, consisting of 4,376,552 Class A ordinary shares of Universe Pharmaceuticals. The transaction has been approved by the company's board of directors and is expected to close in the third quarter of 2026, subject to customary closing conditions.&lt;/p&gt;&lt;p&gt;The five patents cover areas including age-related diseases, neurodegenerative conditions, cognitive disorders, cardiovascular</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Universe+Pharmaceuticals+to+acquire+five-patent+portfolio+for+%2410.75M/26698691.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:06:04 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Universe Pharmaceuticals to acquire five-patent portfolio for $10.75M</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Universe+Pharmaceuticals+to+acquire+five-patent+portfolio+for+%2410.75M/26698691.html</link>
   <description>&lt;p&gt;Universe Pharmaceuticals INC (NASDAQ: UPC), a pharmaceutical producer and distributor based in Ji'an, Jiangxi, China, has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited, a company holding five patents in China, for $10,751,000.&lt;/p&gt;&lt;p&gt;The purchase price will be paid entirely in stock, consisting of 4,376,552 Class A ordinary shares of Universe Pharmaceuticals. The transaction has been approved by the company's board of directors and is expected to close in the third quarter of 2026, subject to customary closing conditions.&lt;/p&gt;&lt;p&gt;The five patents cover areas including age-related diseases, neurodegenerative conditions, cognitive disorders, cardiovascular</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Universe+Pharmaceuticals+to+acquire+five-patent+portfolio+for+%2410.75M/26698691.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:06:04 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio</title>
   <link>http://www.streetinsider.com/Press+Releases/Universe+Pharmaceuticals+INC+Announces+Strategic+Acquisition+to+Expand+Pharmaceutical+Patent+Portfolio/26698653.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Ji&amp;#39;an, Jiangxi, China, June  26, 2026  (GLOBE NEWSWIRE) --  Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The patent portfolio covers several pharmaceutical and healthcare-related</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Universe+Pharmaceuticals+INC+Announces+Strategic+Acquisition+to+Expand+Pharmaceutical+Patent+Portfolio/26698653.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Universe+Pharmaceuticals+INC+Announces+Strategic+Acquisition+to+Expand+Pharmaceutical+Patent+Portfolio/26698653.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Ji&amp;#39;an, Jiangxi, China, June  26, 2026  (GLOBE NEWSWIRE) --  Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The patent portfolio covers several pharmaceutical and healthcare-related</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Universe+Pharmaceuticals+INC+Announces+Strategic+Acquisition+to+Expand+Pharmaceutical+Patent+Portfolio/26698653.html</guid>
   <pubDate>Fri, 26 Jun 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  4          Universe Pharmaceuticals  For: May 07  Filed by: Lai Gang</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Universe+Pharmaceuticals++For%3A+May+07++Filed+by%3A+Lai+Gang/26535609.html</link>
   <description>si-local-file:///var/storage/secattach/20260521/26535609.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Universe+Pharmaceuticals++For%3A+May+07++Filed+by%3A+Lai+Gang/26535609.html</guid>
   <pubDate>Thu, 21 May 2026 16:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  4          Universe Pharmaceuticals  For: May 07  Filed by: Lai Gang</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Universe+Pharmaceuticals++For%3A+May+07++Filed+by%3A+Lai+Gang/26535609.html</link>
   <description>si-local-file:///var/storage/secattach/20260521/26535609.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Universe+Pharmaceuticals++For%3A+May+07++Filed+by%3A+Lai+Gang/26535609.html</guid>
   <pubDate>Thu, 21 May 2026 16:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D  Universe Pharmaceuticals               Filed by: Lai Gang</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Universe+Pharmaceuticals+++++++++++++++Filed+by%3A+Lai+Gang/26535568.html</link>
   <description>si-local-file:///var/storage/secattach/20260521/26535568.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Universe+Pharmaceuticals+++++++++++++++Filed+by%3A+Lai+Gang/26535568.html</guid>
   <pubDate>Thu, 21 May 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13D  Universe Pharmaceuticals               Filed by: Lai Gang</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Universe+Pharmaceuticals+++++++++++++++Filed+by%3A+Lai+Gang/26535568.html</link>
   <description>si-local-file:///var/storage/secattach/20260521/26535568.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++Universe+Pharmaceuticals+++++++++++++++Filed+by%3A+Lai+Gang/26535568.html</guid>
   <pubDate>Thu, 21 May 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: May 14</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+May+14/26494936.html</link>
   <description>si-local-file:///var/storage/secattach/20260514/26494936.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+May+14/26494936.html</guid>
   <pubDate>Thu, 14 May 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: May 14</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+May+14/26494936.html</link>
   <description>si-local-file:///var/storage/secattach/20260514/26494936.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+May+14/26494936.html</guid>
   <pubDate>Thu, 14 May 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: Apr 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Apr+16/26325070.html</link>
   <description>si-local-file:///var/storage/secattach/20260416/26325070.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Apr+16/26325070.html</guid>
   <pubDate>Thu, 16 Apr 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  6-K        Universe Pharmaceuticals  For: Apr 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Apr+16/26325070.html</link>
   <description>si-local-file:///var/storage/secattach/20260416/26325070.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Universe+Pharmaceuticals++For%3A+Apr+16/26325070.html</guid>
   <pubDate>Thu, 16 Apr 2026 16:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  3          Universe Pharmaceuticals  For: Mar 18  Filed by: Zheng Ding</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Universe+Pharmaceuticals++For%3A+Mar+18++Filed+by%3A+Zheng+Ding/26180146.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26180146.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Universe+Pharmaceuticals++For%3A+Mar+18++Filed+by%3A+Zheng+Ding/26180146.html</guid>
   <pubDate>Wed, 18 Mar 2026 08:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  3          Universe Pharmaceuticals  For: Mar 18  Filed by: Zheng Ding</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Universe+Pharmaceuticals++For%3A+Mar+18++Filed+by%3A+Zheng+Ding/26180146.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26180146.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Universe+Pharmaceuticals++For%3A+Mar+18++Filed+by%3A+Zheng+Ding/26180146.html</guid>
   <pubDate>Wed, 18 Mar 2026 08:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
  <item>
   <title>Form  3          Universe Pharmaceuticals  For: Mar 18  Filed by: Lai Gang</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Universe+Pharmaceuticals++For%3A+Mar+18++Filed+by%3A+Lai+Gang/26180139.html</link>
   <description>si-local-file:///var/storage/secattach/20260318/26180139.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Universe+Pharmaceuticals++For%3A+Mar+18++Filed+by%3A+Lai+Gang/26180139.html</guid>
   <pubDate>Wed, 18 Mar 2026 08:26:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.50244271</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">UPC</category>
   	  </item>
 </channel>
</rss>
